Print
Health Care

PPD Adds Clinical Research Site In Florida

By Vicky Janowski, posted Dec 20, 2019
Wilmington-based PPD now has a 52-bed clinical research unit in Orlando, Florida, with a focus on early phase trials on neurological disorders, company officials announced in December.

The addition to PPD’s portfolio came as part of its acquisition of Bioclinica’s clinical research site business. That move by PPD subsidiary Accelerated Enrollment Solutions, which was announced in September, grew AES’ footprint to across 20 countries and more than 180 research sites.

The Orlando unit includes individual bedrooms for special patient populations, such as elderly Alzheimer’s patients, according to a PPD news release.

“The recently acquired unit [in Orlando] has a strong track record of recruiting and conducting early phase trials in multiple neurological indications, such as Alzheimer’s disease, which affects aging populations,” the release stated. “The Orlando CRU has completed over 50 Phase I studies in Alzheimer’s and other central nervous system/neurodegenerative therapeutic areas.”

With the Orlando facility, PPD now has three clinical research units for early-phase studies.

In Las Vegas, the company has a 24-bed unit adjacent to a hospital campus that specializes in endocrinology and metabolic trials. There it has also started to conduct Japanese ethno-bridging studies in which Japanese volunteers who have lived in the U.S. for less than five years participate in studies, allowing biopharmaceutical companies to incorporate Asian patient data so that Phase II studies can be initiated in Asian markets sooner.

“By tapping into nearby high-concentration Japanese communities, we are able to study the way this population metabolizes medications and recommend alterations in safety, efficacy or dosages,” said Scott Dove, vice president of early development at PPD, in a news release. “In addition to ethno-bridging, we have expanded our distinct capabilities in neuroscience and other niche therapeutic areas to study patient populations more reflective of the products’ end-users. Increasing client access to special patient populations opens exciting opportunities for the development of important new therapies to address unmet medical needs.”

PPD’s third unit is a 185-bed clinic in Austin, Texas.
Ico insights

INSIGHTS

SPONSORS' CONTENT
Michaelhiggins 41019104338

Pre-Planning Essentials For The Frequent Traveler

Michael Higgins - Dignity Memorial
Lynnwhitecell hwconsulting headshot

7 Tips For Delegating Better

Lynn Whitesell - Harris Whitesell Consulting
Hardy revised

The Future Of Health Care: Administration

Charles Hardy - UNCW College of Health and Human Services

Trending News

Live Oak Bank Sprouts A Presence In Raleigh

Jenny Callison - Jan 20, 2020

Alcami Acquires TriPharm Services

Christina Haley O'Neal - Jan 20, 2020

In The Current Issue

Startups To Watch In 2020

As technology becomes increasingly more embedded into our everyday lives, some Wilmington startups are on the rise....


Teaming Up: Are Public-private Partnerships In Area's Future?

Officials in the region and beyond are bringing public-private partnerships to the table as potential solutions to public needs that could a...


MADE: Driven To Expand Business

South Atlantic Services is a Wilmington-headquartered contract manufacturing and packaging company that makes automotive and industrial cool...

Book On Business

The 2019 WilmingtonBiz: Book on Business is an annual publication showcasing the Wilmington region as a center of business.

Order Your Copy Today!


Galleries

Videos

2019 Health Care Heroes
August 26, 2019 Power Breakfast: A Healthy Sale?
2019 WILMA Leadership Accelerator
2019 WilmingtonBiz Expo Keynote Lunch - CEO, nCino, Pierre Naude`